IBM Files 8-K with Financial Statements and Exhibits

TL;DR

IBM filed an 8-K on 3/18/24 with financial statements and details on its various notes due in upcoming years.

AI Summary

On March 18, 2024, International Business Machines Corp. (IBM) filed an 8-K, primarily to disclose financial statements and exhibits. The filing includes details on various debt instruments, such as IBM's 1.125% Notes due 2024 and 0.950% Notes due 2025, indicating ongoing financial management and reporting activities.

Why It Matters

This filing provides a routine update on IBM's financial reporting and debt structure, offering transparency to investors about the company's financial health and obligations.

Risk Assessment

Risk Level: low — This is a standard financial filing with no new material events or significant changes reported.

Key Players & Entities

• INTERNATIONAL BUSINESS MACHINES CORP (company) — Filer
• IBM (company) — Commonly referred name
• 1.125% Notes due 2024 (dollar_amount) — Debt instrument
• 2.875% Notes due 2025 (dollar_amount) — Debt instrument
• 0.950% Notes due 2025 (dollar_amount) — Debt instrument
• 0.875% Notes due 2025 (dollar_amount) — Debt instrument
• 0.300% Notes due 2026 (dollar_amount) — Debt instrument
• 1.250% Notes due 2027 (dollar_amount) — Debt instrument
• 3.375% Notes due 2027 (dollar_amount) — Debt instrument
• 0.300% Notes due 2028 (dollar_amount) — Debt instrument

FAQ

Filing Documents

• ibm-20240318.htm (8-K) — 66KB
• march2024investorarticle.htm (EX-99.1) — 2KB
• march2024investorarticle001.jpg (GRAPHIC) — 132KB
• march2024investorarticle002.jpg (GRAPHIC) — 91KB
• march2024investorarticle003.jpg (GRAPHIC) — 141KB
• march2024investorarticle004.jpg (GRAPHIC) — 132KB
• march2024investorarticle005.jpg (GRAPHIC) — 93KB
• 0000051143-24-000015.txt ( ) — 1209KB
• ibm-20240318.xsd (EX-101.SCH) — 8KB
• ibm-20240318_def.xml (EX-101.DEF) — 29KB
• ibm-20240318_lab.xml (EX-101.LAB) — 58KB
• ibm-20240318_pre.xml (EX-101.PRE) — 30KB
• ibm-20240318_htm.xml (XML) — 25KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On February 26, 2024, IBM announced that it is updating its reportable segments in the first quarter 2024 to reflect the way the company manages operations and allocates resources. There is no change to IBM's consolidated results. Exhibit 99.1 to this Form 8-K contains information that the company has posted on its Investor Relations website (www.ibm.com/investor/) providing recast historical segment financials for 2022 and 2023. In addition, it includes reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The information in this Item 7.01, including Exhibit 99.1, is being furnished with the Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is being furnished as part of this report: Exhibit No. Description of Exhibit 99.1 Investor Relations Article, dated March 18, 2024 The following exhibit is being filed as part of this report: Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) IBM's web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: March 18, 2024 By: /s/ Nicols A. Fehring Nicols A. Fehring Vice President and Controller 3

View Full Filing

View this 8-K filing on SEC EDGAR